Skip to search.
 TSX Up 0.10% TSX Ventures Down 0.27%

Seattle Genetics, Inc. (SGEN)

-NasdaqGS
37.14 Down 0.36(0.96%) Apr 24, 4:00PM EDT
|After Hours : 37.14 0.00 (0.00%) Apr 24, 4:03PM EDT
Add to Portfolio
Prev Close:37.50
Open:37.55
Bid:36.65 x 1000
Ask:39.00 x 1000
1y Target Est:42.60
Beta:2.36
Next Earnings Date:30-Apr-15SGEN Earnings announcement
Day's Range:37.12 - 38.29
52wk Range:30.05 - 44.95
Volume:794,243
Avg Vol (3m):1,102,530
Market Cap:4.63B
P/E (ttm):N/A
EPS (ttm):-0.62
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
SGENDown 0.96%4.63B
IMGNDown 2.83%857.64M
PFEDown 0.25%216.57B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.26
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.71
Quarterly EPS Est (Mar-15) :-0.19
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):-2.00

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback